Cargando…
Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies
Organ fibrosis often ends in eventual organ failure and leads to high mortality. Although researchers have identified many effector cells and molecular pathways, there are few effective therapies for fibrosis to date and the underlying mechanism needs to be examined and defined further. Epoxyeicosat...
Autores principales: | Guan, Xin-Xin, Rao, Dong-Ning, Liu, Yan-Zhe, Zhou, Yong, Yang, Hui-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509622/ https://www.ncbi.nlm.nih.gov/pubmed/34639055 http://dx.doi.org/10.3390/ijms221910714 |
Ejemplares similares
-
The arachidonic acid metabolite 11,12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis
por: Kim, Hak Su, et al.
Publicado: (2021) -
Aging, Estrogen Loss and Epoxyeicosatrienoic Acids (EETs)
por: Lee, Alison R., et al.
Publicado: (2013) -
Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition
por: Skibba, Melissa, et al.
Publicado: (2017) -
Anti-Inflammatory Effects of Epoxyeicosatrienoic Acids
por: Thomson, Scott J., et al.
Publicado: (2012) -
The role of epoxyeicosatrienoic acids in the cardiovascular system
por: Yang, L, et al.
Publicado: (2015)